{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:57Z","timestamp":1787041677625,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41401-026-01825-6","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:41:49Z","timestamp":1781138509000},"page":"2539-2553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum\/glucocorticoid-regulated kinase 1 regulates vascular inflammation in atherosclerosis"],"prefix":"10.1038","volume":"47","author":[{"given":"Yang-xian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-xiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-ling","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-meng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin-hang","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Kwok-Wing","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-lan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"1825_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"1825_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5:56.","journal-title":"Nat Rev Dis Primers"},{"key":"1825_CR3","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.clinthera.2023.09.020","volume":"45","author":"L Nedkoff","year":"2023","unstructured":"Nedkoff L, Briffa T, Zemedikun D, Herrington S, Wright FL. Global trends in atherosclerotic cardiovascular disease. Clin Ther. 2023;45:1087\u201391.","journal-title":"Clin Ther"},{"key":"1825_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","volume":"67","author":"P Libby","year":"2021","unstructured":"Libby P. Inflammation in atherosclerosis\u2014no longer a theory. Clin Chem. 2021;67:131\u201342.","journal-title":"Clin Chem"},{"key":"1825_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri3908","volume":"15","author":"D Vestweber","year":"2015","unstructured":"Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol. 2015;15:692\u2013704.","journal-title":"Nat Rev Immunol"},{"key":"1825_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/ATVBAHA.124.320151","volume":"44","author":"A Wendelboe","year":"2024","unstructured":"Wendelboe A, Weitz JI. Global health burden of venous thromboembolism. Arterioscler Thromb Vasc Biol. 2024;44:1007\u201311.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1825_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7:131.","journal-title":"Signal Transduct Target Ther"},{"key":"1825_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis\u2014an inflammatory disease. N Engl J Med. 1999;340:115\u201326.","journal-title":"N Engl J Med"},{"key":"1825_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2021.09.024","volume":"335","author":"E Lutgens","year":"2021","unstructured":"Lutgens E, Joffre J, van Os B, Ait-Oufella H. Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies. Atherosclerosis. 2021;335:98\u2013109.","journal-title":"Atherosclerosis"},{"key":"1825_CR10","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/pharmaceutics14071395","volume":"14","author":"L Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez L, Bulnes JF, Orellana MP, Mu\u00f1oz Venturelli P, Mart\u00ednez Rodriguez G. The role of colchicine in atherosclerosis: from bench to bedside. Pharmaceutics. 2022;14:1395.","journal-title":"Pharmaceutics"},{"key":"1825_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07166-8","volume":"15","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A, Pratico D, Lin L, Mantzoros CS, Bahijri S, Tuomilehto J, et al. Inflammation in atherosclerosis: pathophysiology and mechanisms. Cell Death Dis. 2024;15:817.","journal-title":"Cell Death Dis"},{"key":"1825_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15698\/cst2019.01.170","volume":"3","author":"F Lang","year":"2018","unstructured":"Lang F, Stournaras C, Zacharopoulou N, Voelkl J, Alesutan I. Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress. Cell Stress. 2018;3:1\u20138.","journal-title":"Cell Stress"},{"key":"1825_CR13","doi-asserted-by":"crossref","unstructured":"Della-Morte D, Pastore D, Capuani B, Pacifici F, Lauro D. SGK-1 (serum- and glucocorticoid-inducible kinase-1). In: Choi S, editor. Encyclopedia of signaling molecules. Cham: Springer; 2018.","DOI":"10.1007\/978-3-319-67199-4_101807"},{"key":"1825_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/ph13110413","volume":"13","author":"I Guerriero","year":"2020","unstructured":"Guerriero I, Monaco G, Coppola V, Orlacchio A. Serum and glucocorticoid-inducible kinase 1 (SGK1) in NSCLC therapy. Pharmaceuticals. 2020;13:413.","journal-title":"Pharmaceuticals"},{"key":"1825_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/BJ20081668","volume":"416","author":"JM Garc\u00eda-Mart\u00ednez","year":"2008","unstructured":"Garc\u00eda-Mart\u00ednez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J. 2008;416:375\u201385.","journal-title":"Biochem J"},{"key":"1825_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature11868","volume":"496","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013;496:518\u201322.","journal-title":"Nature"},{"key":"1825_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature11984","volume":"496","author":"C Wu","year":"2013","unstructured":"Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature. 2013;496:513\u20137.","journal-title":"Nature"},{"key":"1825_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/HYPERTENSIONAHA.119.12761","volume":"74","author":"JP Van Beusecum","year":"2019","unstructured":"Van Beusecum JP, Barbaro NR, McDowell Z, Aden LA, Xiao L, Pandey AK, et al. High salt activates CD11c+ antigen-presenting cells via SGK (serum glucocorticoid kinase) 1 to promote renal inflammation and salt-sensitive hypertension. Hypertension. 2019;74:555\u201363.","journal-title":"Hypertension"},{"key":"1825_CR19","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1074\/jbc.M805055200","volume":"284","author":"DJ Tai","year":"2009","unstructured":"Tai DJ, Su CC, Ma YL, Lee EH. SGK1 phosphorylation of IkappaB kinase alpha and p300 up-regulates NF-kappaB activity and increases N-methyl-D-aspartate receptor NR2A and NR2B expression. J Biol Chem. 2009;284:4073\u201389.","journal-title":"J Biol Chem."},{"key":"1825_CR20","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.3390\/ijms21197207","volume":"21","author":"F Poetsch","year":"2020","unstructured":"Poetsch F, Henze LA, Estepa M, Moser B, Pieske B, Lang F, et al. Role of SGK1 in the osteogenic transdifferentiation and calcification of vascular smooth muscle cells promoted by hyperglycemic conditions. Int J Mol Sci. 2020;21:7207.","journal-title":"Int J Mol Sci"},{"key":"1825_CR21","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1172\/JCI96477","volume":"128","author":"J Voelkl","year":"2018","unstructured":"Voelkl J, Luong TT, Tuffaha R, Musculus K, Auer T, Lian X, et al. SGK1 induces vascular smooth muscle cell calcification through NF-\u03baB signaling. J Clin Invest. 2018;128:3024\u201340.","journal-title":"J Clin Invest"},{"key":"1825_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/ATVBAHA.114.304454","volume":"35","author":"O Borst","year":"2015","unstructured":"Borst O, Schaub M, Walker B, Schmid E, M\u00fcnzer P, Voelkl J, et al. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. Arterioscler Thromb Vasc Biol. 2015;35:547\u201357.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1825_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/FJC.0000000000001316","volume":"80","author":"H Yamamoto","year":"2022","unstructured":"Yamamoto H, Yoshida N, Kihara S. Esaxerenone blocks vascular endothelial inflammation through SGK1. J Cardiovasc Pharmacol. 2022;80:583\u201391.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1825_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0647-1","volume":"11","author":"J Matschke","year":"2016","unstructured":"Matschke J, Wiebeck E, Hurst S, Rudner J, Jendrossek V. Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia. Radiat Oncol. 2016;11:75.","journal-title":"Radiat Oncol"},{"key":"1825_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10644-0","volume":"25","author":"Z Lei","year":"2024","unstructured":"Lei Z, Pan C, Li F, Wei D, Ma Y. SGK1 promotes the lipid accumulation via regulating the transcriptional activity of FOXO1 in bovine. BMC Genom. 2024;25:737.","journal-title":"BMC Genom"},{"key":"1825_CR26","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DGNC3Rs Reporting Guidelines Working Group Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol. 2010;160:1577\u20139.","journal-title":"Br J Pharmacol"},{"key":"1825_CR27","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: a free online platform for data visualization and graphing. PLoS One. 2023;18:e0294236.","journal-title":"PLoS One"},{"key":"1825_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1091\/mbc.e02-03-0170","volume":"14","author":"AC Maiyar","year":"2003","unstructured":"Maiyar AC, Leong ML, Firestone GL. Importin-alpha mediates the regulated nuclear targeting of serum- and glucocorticoid-inducible protein kinase (Sgk) by recognition of a nuclear localization signal in the kinase central domain. Mol Biol Cell. 2003;14:1221\u201339.","journal-title":"Mol Biol Cell"},{"key":"1825_CR29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125\u201331.","journal-title":"J Clin Invest"},{"key":"1825_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","volume":"86","author":"D Eberl\u00e9","year":"2004","unstructured":"Eberl\u00e9 D, Hegarty B, Bossard P, Ferr\u00e9 P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86:839\u201348.","journal-title":"Biochimie"},{"key":"1825_CR31","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1021\/acsptsci.4c00574","volume":"7","author":"Y Liu","year":"2024","unstructured":"Liu Y, Lu K, Zhang R, Hu D, Yang Z, Zeng J, et al. Advancements in the treatment of atherosclerosis: from conventional therapies to cutting-edge innovations. ACS Pharmacol Transl Sci. 2024;7:3804\u201326.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1825_CR32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331.","journal-title":"N Engl J Med"},{"key":"1825_CR33","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","volume":"397","author":"PM Ridker","year":"2021","unstructured":"Ridker PM, Devalaraja M, Baeres FMM, Engelmann MDM, Hovingh GK, Ivkovic M, et al. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2021;397:2060\u20139.","journal-title":"Lancet"},{"key":"1825_CR34","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383:1838\u201347.","journal-title":"N Engl J Med"},{"key":"1825_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","volume":"120","author":"PM Ridker","year":"2017","unstructured":"Ridker PM. How common is residual inflammatory risk?. Circ Res. 2017;120:617\u20139.","journal-title":"Circ Res"},{"key":"1825_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/ATVBAHA.124.321421","volume":"45","author":"S Leng","year":"2025","unstructured":"Leng S, Li H, Zhang P, Dang Z, Shao B, Xue S, et al. SGK1-mediated vascular smooth muscle cell phenotypic transformation promotes thoracic aortic dissection progression. Arterioscler Thromb Vasc Biol. 2025;45:238\u201359.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1825_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155831","volume":"154","author":"L Zhang","year":"2024","unstructured":"Zhang L, Sun Z, Yang Y, Mack A, Rodgers M, Aroor A, et al. Endothelial cell serum and glucocorticoid regulated kinase 1 (SGK1) mediates vascular stiffening. Metabolism. 2024;154:155831.","journal-title":"Metabolism"},{"key":"1825_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ajhg.2023.03.013","volume":"110","author":"T \u00d6rd","year":"2023","unstructured":"\u00d6rd T, L\u00f6nnberg T, Nurminen V, Ravindran A, Niskanen H, Kiema M, et al. Dissecting the polygenic basis of atherosclerosis via disease-associated cell state signatures. Am J Hum Genet. 2023;110:722\u201340.","journal-title":"Am J Hum Genet"},{"key":"1825_CR39","first-page":"8","volume":"9","author":"Y Feng","year":"2025","unstructured":"Feng Y, Li C, Chen J, Xiao X, Mao Q, Zhao H, et al. Endothelial dysfunction in atherosclerosis: from classical pathways to emerging mechanisms. Vessel Plus. 2025;9:8.","journal-title":"Vessel Plus"},{"key":"1825_CR40","first-page":"43","volume":"5","author":"N Liu","year":"2021","unstructured":"Liu N, Zhang B, Sun Y, Song W, Guo S. Macrophage origin, phenotypic diversity, and modulatory signaling pathways in the atherosclerotic plaque microenvironment. Vessel Plus. 2021;5:43.","journal-title":"Vessel Plus"},{"key":"1825_CR41","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fphys.2018.01581","volume":"9","author":"YN Du","year":"2018","unstructured":"Du YN, Tang XF, Xu L, Chen WD, Gao PJ, Han WQ. SGK1-FoxO1 signaling pathway mediates Th17\/Treg imbalance and target organ inflammation in angiotensin II-induced hypertension. Front Physiol. 2018;9:1581.","journal-title":"Front Physiol"},{"key":"1825_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-01753-z","volume":"9","author":"JB Xu","year":"2024","unstructured":"Xu JB, Guan WJ, Zhang YL, Zhuo EQ, Chen L, Hou XC, et al. SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl- concentration. Signal Transduct Target Ther. 2024;9:74.","journal-title":"Signal Transduct Target Ther"},{"key":"1825_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.devcel.2022.02.004","volume":"57","author":"S Vaidyanathan","year":"2022","unstructured":"Vaidyanathan S, Salmi TM, Sathiqu RM, McConville MJ, Cox AG, Brown KK. YAP regulates an SGK1\/mTORC1\/SREBP-dependent lipogenic program to support proliferation and tissue growth. Dev Cell. 2022;57:719\u201331.e8.","journal-title":"Dev Cell"},{"key":"1825_CR44","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/ATVBAHA.110.219659","volume":"31","author":"T Karasawa","year":"2011","unstructured":"Karasawa T, Takahashi A, Saito R, Sekiya M, Igarashi M, Iwasaki H, et al. Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2011;31:1788\u201395.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1825_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000093","volume":"2","author":"Y Liu","year":"2013","unstructured":"Liu Y, Major AS, Zienkiewicz J, Gabriel CL, Veach RA, Moore DJ, et al. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver. J Am Heart Assoc. 2013;2:e000093.","journal-title":"J Am Heart Assoc"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01825-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01825-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01825-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:27Z","timestamp":1787040267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01825-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1825"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01825-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}